Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancerKazuma Iwata(Okayama University), Shinichi Toyooka(Okayama University Hospital)Japanese Journal of Clinical OncologyMay 4, 202410.1093/jjco/hyae058Cited by 8SaveCiteExport RISWatch citationsRelated PapersImmune evasion through mitochondrial transfer in the tumour microenvironment|Nature|2025|239Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features|Scientific Reports|2017|60Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer|PLoS ONE|2017|41Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer|Oncology Letters|2017|28Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer|PLoS ONE|2014|27